Ambroxol Hydrochloride Injection

Mucosolvan has the characteristics of promoting mucus elimination and dissolving secretions. It can promote the elimination of viscous secretions in the respiratory tract and reduce mucus retention, thus significantly promoting expectoration and improving respiratory conditions. When treated with Mucosolvan, the patient's mucus secretion can be restored to normal. Coughing and sputum volume are usually significantly reduced, and the surfactant of the respiratory mucosa thus exerts its normal protective function.

Ambroxol hydrochloride (also known as ambroxol hydrochloride). Excipients: citric acid monohydrate, disodium hydrogen phosphate dihydrate. Sodium chloride, water for injection, nitrogen.

It is suitable for acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor expectoration function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. It is also used for preventive treatment of postoperative pulmonary complications.

1. Adults and children over 12 years old: 2-3 times a day, 1 ampoule each time, slow intravenous infusion; 2. In severe cases, it can be increased to 2 ampoules each time. 3. Children aged 6-12 years: 2-3 times a day, 1 ampoule each time. 4. Children aged 2-6 years: 3 times a day, 1/2 ampoule each time. 5. Children under 2 years old: 2 times a day, 1/2 ampoule each time. 6. All are slow intravenous infusions. Treatment of infant respiratory distress syndrome (IRDS): 1. The total daily medication is calculated based on the infant's weight, 30 mg/kg, divided into 4 doses. 2. A syringe pump should be used for administration, and the intravenous injection time should be at least 5 minutes. 3. This injection can also be mixed with glucose, fructose, saline or Ringer's solution for intravenous drip. 4. This product (pH5.0) cannot be mixed with other solutions with a pH greater than 6.3, because the increase in pH will lead to the precipitation of the free base of this product.

This product is usually well tolerated. Mild upper gastrointestinal adverse reactions have been reported (mainly heartburn, indigestion and occasional nausea and vomiting). Allergic reactions are rare, mainly rash. Severe acute allergic reactions have been reported in rare cases, but their relevance to amino acid bromoxynil hydrochloride is not certain. Such patients are usually allergic to other substances.

1. People who are known to be allergic to ambroxol hydrochloride or other ingredients in the formula should not use this product. 2. Pregnant women should use this product with caution.

Precautions for children: See [Usage and Dosage]. Precautions for pregnancy and lactation: Use with caution for pregnant women. Precautions for the elderly: No special precautions.

The synergistic treatment of this product with antibiotics (amoxicillin, cefuroxime, erythromycin, doxycycline) can increase the concentration of antibiotics in lung tissue, and there are no reports of clinically relevant adverse reactions when used in combination with other drugs.

Please store in a sealed container below 30 degrees. Please keep out of the reach of children!

2ml:15mg

60 months

China National Medicines Guorui Pharmaceutical Co., Ltd.

• Founded in:

  1998-08-05

• Address:

  No. 16, Chaoyang East Road, Economic and Technological Development Zone, Huainan City, Anhui Province

• Tax NO.:

  9134040072334670XN

• Registered Funds:

  483.0167 million yuan

• Email:

  Log in to view